Phoenix Children’s Hospital Creates $50M Molecular Medicine Institute

Phoenix Children’s Hospital announced the establishment of the $50 million Ronald A. Matricaria Institute of Molecular Medicine to develop targeted drug therapies for children with cancer and other diseases.

Advertisement

The institute is supported by a collaboration between Phoenix Children’s, The University of Arizona College of Medicine-Phoenix and the Translational Genomics Research Institute.

The institute’s goal is to use molecular medicine to develop individualized drugs for patients based on their genetic makeup. The team at the institute will focus on pediatric cancers first, and later expand to other pediatric diseases.

More Articles on Hospitals for Children:

6 Considerations Unique to Children’s Hospitals in the Drive to Greater Healthcare Value
Moody’s: 100 Statistics on Children’s Hospital Medians

Children’s Hospitals and Clinics of Minnesota Opens New ED

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.